Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00706
|
|||||
| Drug Name |
Cefuroxime
|
|||||
| Synonyms |
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester); 3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid; Anaptivan; Biociclin; Biofuroksym; Bioxima; CEFUROXIME SODIUM; CXM; Cefofix; Ceftin (TN); Cefumax; Cefurex; Cefuril; Cefuroxim; Cefuroxim AJ; Cefuroxim Fresenius; Cefuroxim Genericsn; Cefuroxim Hexal; Cefuroxim Lilly; Cefuroxim MN; Cefuroxim Norcox; Cefuroxim Norcox [inj.]; Cefuroxim curasan; Cefuroxima Fabra; Cefuroxima Richet; Cefuroxime (TN); Cefuroxime (USAN/INN); Cefuroxime [USAN:INN:BAN]; Cefuroxime for Injection and Dextrose for Injection in Duplex Container; Cefuroxime na; Cefuroxime sodium (JP15/USP); Cefuroxime sodium [USAN:BAN:JAN]; Cefuroxime sodium salt; Cefuroximesodium; Cefuroximine; Cefuroximo; Cefuroximo [INN-Spanish]; Cefuroximum; Cefuroximum [INN-Latin]; Cephuroxime; Cetroxil; Cetroxil [inj.]; Colifossim; Curocef; Curoxim; Curoxima; Curoxime; Froxal; Froxal [inj.]; Furoxil; KEFUROX IN PLASTIC CONTAINER; KS-1040; Kesint; Ketocef; Lifurox; Medoxim; Sharox; Sharox [inj.]; Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester); Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Sodium cefuroxime; Spectrazolr; Ultroxim; ZINACEF IN PLASTIC CONTAINER; Zinacef (TN); Zinacef Danmark; Zinacef;CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER; Zinnat (TN); Zinnat [inj.]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H15N4NaO8S
|
|||||
| Canonical SMILES |
CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]
|
|||||
| InChI |
InChI=1S/C16H16N4O8S.Na/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20;/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24);/q;+1/p-1/b19-9-;/t10-,14-;/m1./s1
|
|||||
| InChIKey |
URDOHUPGIOGTKV-JTBFTWTJSA-M
|
|||||
| CAS Number |
CAS 55268-75-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 446.4 | Topological Polar Surface Area | 202 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 10 | |||
| PubChem CID | ||||||
| PubChem SID |
10308
, 117664401
, 121363576
, 124766425
, 126629706
, 126655800
, 126686329
, 135004234
, 137267224
, 14833063
, 14881773
, 152101191
, 162225020
, 163316243
, 164788191
, 170524605
, 175265786
, 175611978
, 179316275
, 187072187
, 196112116
, 223439274
, 223674139
, 227008553
, 24892692
, 252122164
, 252402066
, 25819900
, 43176102
, 50050864
, 56041334
, 57260152
, 57264411
, 57387187
, 57654015
, 77146479
, 7847978
, 8139982
, 89736081
, 92713907
|
|||||
| ChEBI ID |
ChEBI:3515
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.